Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 999 | 1207 | 1154 | 1038 | 1630 | 2571 |
Fund Return | -0.09% | 20.72% | 15.36% | 1.26% | 10.26% | 9.9% |
Place in category | 257 | 115 | 95 | 159 | 258 | 163 |
% in Category | 40 | 21 | 16 | 36 | 50 | 41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guggenheim Risk Managed Real Estt I | 319.96M | 8.49 | 0.92 | 8.34 | ||
Guggenheim Mid Cap Value A | 288.26M | -2.10 | 9.01 | 7.44 | ||
Guggenheim Variable Funds Series A | 254.63M | 1.96 | 9.89 | 12.29 | ||
Guggenheim StylePlus - Large Core A | 253.32M | 1.98 | 9.53 | 11.84 | ||
Guggenheim Variable Funds Series J | 176.77M | -0.13 | 1.17 | 10.20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 13.77B | 16.92 | 6.22 | 12.50 | ||
T. Rowe Price Mid-Cap Growth I | 12.69B | 8.43 | 0.52 | - | ||
T. Rowe Price Mid-Cap Growth | 12.66B | 8.34 | 0.39 | 10.65 | ||
Vanguard Mid-Cap Growth Index Admir | 11.88B | 8.64 | -0.71 | 9.98 | ||
T. Rowe Price New Horizons I | 10.31B | 1.98 | -10.08 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Guggenheim Strategy III | - | 36.50 | - | - | |
Guggenheim Strategy II | - | 34.24 | - | - | |
Russell MidCap Growth Index Total Return | - | 7.95 | - | - | |
Guggenheim Ultra Short Duration Instl | - | 3.28 | - | - | |
United Therapeutics | US91307C1027 | 0.47 | 357.72 | -0.50% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review